Boston Scientific Gains Distal Protection Market Entry With EPI's Filterwire
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's $75 mil. acquisition of Embolic Protection, Inc. provides an immediate entry into the vascular distal protection market.
You may also be interested in...
Boston Scientific Carotid Stent 2004 Launch Will Court Vascular Surgeons
Boston Scientific will complete enrollment of its 775-patient U.S. pivotal carotid stent trial by year-end
Boston Scientific Carotid Stent 2004 Launch Will Court Vascular Surgeons
Boston Scientific will complete enrollment of its 775-patient U.S. pivotal carotid stent trial by year-end
Boston Scientific Looking To Expand Urology/Gynecology Product Offerings
Boston Scientific remains open to the possibility of making an acquisition in the urology or gynecology area to boost the current 8-10% rate of revenue growth.